DISORDERS OF SPHINGOLIPID METABOLISM

Clinical trials for DISORDERS OF SPHINGOLIPID METABOLISM explained in plain language.

Never miss a new study

Get alerted when new DISORDERS OF SPHINGOLIPID METABOLISM trials appear

Sign up with your email to follow new studies for DISORDERS OF SPHINGOLIPID METABOLISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Scientists track a Drug's journey through the body

Knowledge-focused Completed

This study aimed to understand how the body absorbs, breaks down, and eliminates the experimental drug venglustat. Six healthy male volunteers received a single, traceable dose. Researchers then measured how much of the drug and its byproducts were excreted in urine and feces ove…

Matched conditions: DISORDERS OF SPHINGOLIPID METABOLISM

Phase: PHASE1 • Sponsor: Genzyme, a Sanofi Company • Aim: Knowledge-focused

Last updated Mar 24, 2026 12:02 UTC

DISORDERS OF SPHINGOLIPID METABOLISM

Get alerted when new DISORDERS OF SPHINGOLIPID METABOLISM trials appear

Scientists track a Drug's journey through the body